GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dizal (Jiangsu) Pharmaceutical Co Ltd (SHSE:688192) » Definitions » Book Value per Share

Dizal (Jiangsu) Pharmaceutical Co (SHSE:688192) Book Value per Share : ¥0.04 (As of Mar. 2025)


View and export this data going back to 2021. Start your Free Trial

What is Dizal (Jiangsu) Pharmaceutical Co Book Value per Share?

Dizal (Jiangsu) Pharmaceutical Co's book value per share for the quarter that ended in Mar. 2025 was ¥0.04.

During the past 12 months, Dizal (Jiangsu) Pharmaceutical Co's average Book Value Per Share Growth Rate was -97.60% per year. During the past 3 years, the average Book Value Per Share Growth Rate was -57.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.

During the past 7 years, the highest 3-Year average Book Value Per Share Growth Rate of Dizal (Jiangsu) Pharmaceutical Co was -11.50% per year. The lowest was -57.60% per year. And the median was -34.55% per year.

Dizal (Jiangsu) Pharmaceutical Co's current price is ¥54.72. Its book value per share for the quarter that ended in Mar. 2025 was ¥0.04. Hence, today's PB Ratio of Dizal (Jiangsu) Pharmaceutical Co is 1,368.00.

During the past 7 years, the highest P/B Ratio of Dizal (Jiangsu) Pharmaceutical Co was 1447.75. The lowest was 3.66. And the median was 11.13.

Warning Sign:

Dizal (Jiangsu) Pharmaceutical Co Ltd stock PB Ratio (=1395) is close to 5-year high of 1447.75.


Dizal (Jiangsu) Pharmaceutical Co Book Value per Share Historical Data

The historical data trend for Dizal (Jiangsu) Pharmaceutical Co's Book Value per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dizal (Jiangsu) Pharmaceutical Co Book Value per Share Chart

Dizal (Jiangsu) Pharmaceutical Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Book Value per Share
Get a 7-Day Free Trial 3.00 6.09 4.32 2.08 0.46

Dizal (Jiangsu) Pharmaceutical Co Quarterly Data
Dec19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Book Value per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.68 1.47 1.03 0.46 0.04

Competitive Comparison of Dizal (Jiangsu) Pharmaceutical Co's Book Value per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Dizal (Jiangsu) Pharmaceutical Co's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dizal (Jiangsu) Pharmaceutical Co's PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Dizal (Jiangsu) Pharmaceutical Co's PB Ratio distribution charts can be found below:

* The bar in red indicates where Dizal (Jiangsu) Pharmaceutical Co's PB Ratio falls into.


;
;

Dizal (Jiangsu) Pharmaceutical Co Book Value per Share Calculation

Dizal (Jiangsu) Pharmaceutical Co's Book Value Per Share for the fiscal year that ended in Dec. 2024 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(193.8-0.0)/417.6
=0.46

Dizal (Jiangsu) Pharmaceutical Co's Book Value Per Share for the quarter that ended in Mar. 2025 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(18.5-0.0)/459.4
=0.04

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Theoretically it is what the shareholders will receive if the company is liquidated. Total Stockholders Equity is a balance sheet item and equal to Total Assets less Total Liabilities of the company.

Book value may include intangible items which may come from the company's past acquisitions. Book value less intangibles is called Tangible Book.


Dizal (Jiangsu) Pharmaceutical Co  (SHSE:688192) Book Value per Share Explanation

Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.

For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.


Dizal (Jiangsu) Pharmaceutical Co Book Value per Share Related Terms

Thank you for viewing the detailed overview of Dizal (Jiangsu) Pharmaceutical Co's Book Value per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Dizal (Jiangsu) Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
Jinghui East Road, Room 4105, Building E (Building 5), Huirong Business Plaza, Xinwu District, Jiangsu Province, Wuxi City, CHN, 201203
Dizal (Jiangsu) Pharmaceutical Co Ltd is engaged in the research and development, production and sales of innovative drugs.
Executives
Directors, senior managers, core technical personn
Wu Qing Yi senior management
Lv Hong Bin senior management
Directors, senior managers
Senior management, core technical personnel
Zheng Li Core technical personnel
Yang Zhen Fan Senior management, core technical personnel
Senior management, core technical personnel
Qiao Wei Jun Core technical personnel
Chen Kan Core technical personnel
Chen Su Qin Senior management, core technical personnel
Zhang Zhi Wei senior management
Senior management, core technical personnel
Senior management, core technical personnel

Dizal (Jiangsu) Pharmaceutical Co Headlines

No Headlines